29 results found.
Enabling Technology and Integrated Selling Strategies Drove Orthopedic Growth in the Third Quarter
The third quarter of 2019 brought some standout performances from large players like Stryker, Medtronic, NuVasive and Globus Medical. DePuy Synthes and Zimmer Biomet made incremental progress in returning to market growth. Notably, the top performing players all have well-established enabling tec...
Xtant Taps New CEO to Lead Turnaround Effort
Xtant reports 3Q19 revenue of USD $15.7MM, -8.9% vs. 3Q18.
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
Xtant Losses Continue in 2Q19 on Lumbar Implant Recall
Xtant reports 2Q19 revenue of USD $15.3MM, -18.5% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Xtant Reports 1Q19 Revenue of $16.7MM, -7% vs. 1Q18
Xtant reports 1Q19 revenue of USD $16.7MM, -7% vs. 1Q18.
Xtant Reports 4Q18 Revenue of $18.3MM, -5.4% vs. 4Q17
Xtant Medical reports 4Q18 revenue of USD $18.3MM, -5.4% vs. 4Q17, with 2018 full year revenue ...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
Xtant Reports 3Q18 Revenue of $17.3MM, -12.7% vs. 3Q17
Xtant reports 3Q18 revenue of US $17.3MM, -12.7% vs. 3Q17.
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
Xtant Medical Posts 1Q18 Revenue
Xtant Medical posted 1Q18 revenue of US $17.9MM, -18.8% vs. 1Q17.
Xtant Medical Reports 3Q17 Revenue
Xtant Medical posted 3Q17 revenue of US $19.8MM, -14.3% vs. 3Q16, with YTD revenue of $63.3MM, -3.4% vs. the...
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Xtant Medical Posts 20.5% Orthobiologics Growth in 2Q17
Xtant Medical posted 2Q17 revenue of US $21.4MM, -0.3% vs. 2Q16, with 1H17 revenue of $43.5MM, +2....
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Xtant Medical 1Q17 Revenue
Xtant Medical posted 1Q17 revenue of US $22.1MM, +5.3% vs. 1Q16.
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
Xtant Medical Posts 4Q16 and 2016 Revenue
Xtant Medical posted 2016 revenue of US $90.0MM, +4.0% vs. 2015, with 4Q16 revenue of $24.5MM, +9.9% v...
Xtant Medical Reports Preliminary 2016/4Q16 Revenue
Xtant Medical announced preliminary 2016 revenue of ~US $90.0MM, with estimated 4Q16 revenue of ~...
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
Xtant Medical Reports 3Q16 Revenue
Xtant Medical posted 3Q16 revenue of US $23.1MM, +10.5% vs. 3Q15.
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
Xtant Medical Reports 2Q16 Revenue
Xtant Medical posted 2Q16 revenue of US $21.5MM, -0.7% vs. 2Q15 as reported.
Xtant Medical Reports 1Q16 Revenue
Xtant Medical posted 1Q16 revenue of US $20.9MM, -3.5% vs. 1Q15 as-reported.
Xtant Medical Reports 4Q15/2015 Revenue
Xtant Medical announced 4Q15 revenue of US $22.3MM, +14.1% from 4Q14, and 2015 revenue of $86.5MM, +11.4%
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group